Mass General Brigham Innovation Overview

  • Investor Type
  • Venture Capital
  • Status
  • Active
  • Professionals
  • 14
Professionals
  • Investments
  • 45
  • Portfolio
  • 5
  • Exits
  • 32
Exits

Mass General Brigham Innovation General Information

Description

Partners HealthCare Innovation is a corporate venture arm of Partners Healthcare based in Boston, Massachusetts. The firm specializes in the commercialization of new medical technologies from Partners' academic medical centers. The firm brings together specialists in medical technology licensing, research contracts, ventures, and business development. The firm also partners with investigators, scientists, and clinicians to translate new medical technology into healthcare practice via a variety of business channels.

Contact Information

Formerly Known As
Partners HealthCare Innovation
Investor Status
Actively Seeking New Investments
Primary Investor Type
Corporate Venture Capital
Other Investor Types
Venture Capital
Primary Office
  • 215 First Street
  • Suite 500
  • Cambridge, MA 02142
  • United States
+1 (857) 000-0000

Mass General Brigham Innovation Investments & Acquisitions (45)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Verve Therapeutics 14-Jan-2021 Early Stage VC 0000 Drug Discovery Clinical Trials - Phase 1
00000000 000000000 26-Oct-2020 00000 00000 00000 Drug Discovery Startup
0000000000 21-Jun-2017 00000 00000 0000 Biotechnology Generating Revenue
0000000 0000000000 01-Dec-2016 00000 00000 0000 Drug Discovery Clinical Trials - Phase 2
0000000 0000000000 24-May-2016 00000 00000 000.00 Diagnostic Equipment Out of Business 00000 000000000
000000000 27-Apr-2016 00000 00000 000 Therapeutic Devices Generating Revenue
00000000000 30-Mar-2016 00000 00000 00.00 Biotechnology Out of Business
000000 00000000 18-Feb-2016 00000 00000 0000 Other Healthcare Technology Systems Generating Revenue/Not Profitable
Quartet Medicine 07-Oct-2015 Early Stage VC 000.00 Biotechnology Out of Business
Selecta Biosciences 08-Sep-2015 Later Stage VC 0000 Drug Discovery Generating Revenue/Not Profitable
You’re viewing 10 of 45 investments and acquisitions. Get the full list »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Mass General Brigham Innovation Exits (32)

Company Name Exit Date Exit Type Exit Size
Verve Therapeutics 17-Jun-2021 IPO 00000
00000000000 30-Oct-2020 000 00 00000000
000000000 0000000 16-Oct-2020 0000000000: 000000
0000000 0000000000 20-Apr-2020 000 00 00000000
000000000 00000000 01-Oct-2019 000 00 00000000
000000 00000000 25-Jul-2019 000 00000
0000000000 02-Nov-2018 000000000000000000 00.00
0000000 0000000000 01-Aug-2018 000000000000000000 00000
XTuit Pharmaceuticals 01-Mar-2018 Out of Business
Quartet Medicine 20-Nov-2017 Out of Business
You’re viewing 10 of 32 exits. Get the full list »

Mass General Brigham Innovation Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Mass General Brigham Innovation Team (73)

Name Title Deals Funds Boards Office
Beth Mollineaux General Manager, Strategic Marketing Cambridge, MA
Diana Schwartzstein Managing Director, Administration and Strategy Cambridge, MA
Lesley Watts Director, B-BIC Operations and Finance Cambridge, MA
John Flynn Director, Business Development Cambridge, MA
Michael Band Director, Business Development Cambridge, MA
You’re viewing 5 of 73 team members. Get the full list »

Mass General Brigham Innovation Co-Investors (17)

Name With Exits Lead Partner Series Industry
ATP (Apple Tree Partners) 1 0 0 Series chart Industry bar
Abingworth Management 0 Series chart Industry bar
Atlas Venture 0 0 Series chart Industry bar
Citadel (Hedge Fund) 0 Series chart Industry bar
Novo Holdings 0 Series chart Industry bar
You’re viewing 5 of 17 co-investors. Get the full list »